Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank

NCT06162546 is registered in ClinicalTrials.gov with Christoph Aufricht as lead sponsor.

NCT NCT06162546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06162546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank
Lead sponsor
Christoph Aufricht
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
December 31, 2033
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

focal segmental glomerulosclerosis, nephrotic syndrome, nephrotic syndrome steroid-resistant, proteinuria